When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Wilms' tumour

最后审阅: 11 Dec 2025
最后更新: 09 Jul 2025

小结

定义

病史和体格检查

关键诊断因素

  • presence of risk factors
  • upper abdominal/flank mass or swelling
完整详情

其他诊断因素

  • abdominal distension
  • abdominal pain
  • hypertension
  • haematuria
  • poor appetite, weight loss, and/or fever
  • pallor
  • shortness of breath
  • hepatomegaly
  • varicocele
  • hypoglycaemia in infancy
  • features of paraneoplastic syndrome
完整详情

危险因素

  • age <5 years
  • congenital urogenital anomalies
  • congenital syndromes
  • family history of Wilms' tumour
  • antenatal exposure to harmful environmental factors
完整详情

诊断性检查

首要检查

  • FBC
  • renal function
  • liver function tests
  • urinalysis
  • serum total protein/albumin
  • coagulation studies
  • serum calcium level
  • abdominal ultrasound
  • CT or MRI abdomen and pelvis
  • CT chest (with or without contrast)
  • chest x-ray
完整详情

需考虑的检查

  • tumour histology
  • genetic testing
  • tumour molecular biomarker testing
完整详情

治疗流程

急症处理

COG criteria

SIOP criteria

持续性治疗

tumour recurrence

撰稿人

作者

James Geller, MD

Professor of Pediatrics

Peckham Center for Cancer and Blood Disorders

Rady Children’s Hospital, San Diego

San Diego

CA

Division of Pediatric Hematology/Oncology

Department of Pediatrics

University of California San Diego

La Jolla

CA

利益声明

JG declares that he was ‘immediate past Chair’ of the Children’s Oncology Group Renal Tumor Committee and is Chair of Children’s Oncology Group Protocol AREN1921. He has provided expert testimony and deposed in two Wilm's tumour cases (without testifying). JG is an author of several references cited in this topic.

Nicholas G. Cost, MD

Associate Professor

Co-Director of the Surgical Oncology Program

Children’s Hospital Colorado

Program Director of the Pediatric Urology Fellowship

Chair of Renal Tumor Committee in Children’s Oncology Group (COG)

University of Colorado

Aurora

CO

利益声明

NGC declares that his wife works as a Senior Medical Officer for Janssen Pharmaceuticals. NGC is an author of several references cited in this topic.

Daniel J. Benedetti, MD, MA

Associate Professor of Pediatrics

Hematology/Oncology

COG Renal Tumor Committee

Vanderbilt University Medical Center

Nashville

TN

利益声明

DJB declares that he has no competing interests. DJB is an author of several references cited in this topic.

Amy E. Armstrong, MD

Assistant Professor of Pediatrics

Division of Pediatric Hematology/Oncology

COG Renal Tumor Committee

Washington University in St. Louis

St. Louis

MO

利益声明

AEA declares that she has no competing interests. AEA is an author of several references cited in this topic.

鸣谢

Drs Geller, Cost, Benedetti, and Armstrong would like to gratefully acknowledge Dr Sandeep Batra, the previous contributor to this topic.

同行评议者

Nadine Deannie Lee, MD

Pediatric Hematologist-Oncologist

Hematology/Oncology

Riley Children's Hospital

Indiana University Health

Indianapolis

IN

Declarações

NDL declares that she has no competing interests.

Norbert Graf, MD

Direktor

Klinik für Pädiatrische Onkologie und Hämatologie

Universitätsklinikum des Saarlandes

Homburg

Germany

Declarações

NG declares that he has no competing interests.

Zelig Tochner, MD

Associate Professor

Radiation Oncology

Children's Hospital of Philadelphia

Philadelphia

PA

Declarações

ZT declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Spreafico F, Fernandez CV, Brok J, et al. Wilms tumour. Nat Rev Dis Primers. 2021 Oct 14;7(1):75.Texto completo  Resumo

Geller JI, Hong AL, Vallance KL, et al. Children's Oncology Group's 2023 blueprint for research: renal tumors. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(suppl 6):e30586.Texto completo  Resumo

Lopyan NM, Ehrlich PF. Surgical management of Wilms tumor (nephroblastoma) and renal cell carcinoma in children and young adults. Surg Oncol Clin N Am. 2021 Apr;30(2):305-23. Resumo

Vujanić GM, Parsons LN, D'Hooghe E, et al. Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's Oncology Group (COG) renal tumour studies: similarities and differences. Histopathology. 2022 Jun;80(7):1026-37. Resumo

van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2017 Dec;14(12):743-52.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal